Biotechnology News

October 16, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted...

October 16, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. has filed its Annual Report (form 10-K) with the SEC. The Company reports it has $14.3M cash in hand to last over 18 months at current rate, sufficient for advancing drug pipeline.

October 16, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Patent and Trademark Office (USPTO) has determined that U.S. Patent No. 5,540,938 (“the ‘938 patent”) is entitled to a full five year patent...

October 16, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Scientists from VCU report findings on the anti-inflammatory effects of Aradigm’s inhaled ciprofloxacin in human bronchial lung cells stimulated by toxins produced by Pseudomonas aeruginosa

October 16, 2012

BURLINGTON, Mass. & ANDOVER, Mass.--(BUSINESS WIRE)--Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, and Royal Philips Electronics (NYSE: PHG, AEX:...

October 16, 2012

RIVERSIDE, Calif.--(BUSINESS WIRE)--Olfactor Laboratories, Inc. has advanced a world-class technology that could make mosquito bites a thing of the past and is preparing to take that technology to market as early as 2013. Following a two-year...

October 16, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Could Stem Cells be Key to Promising Autism Therapy?

October 16, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The clinic was formed in 1996 and is centrally located in Läkarhuset at Odenplan. It is thus well positioned in Stockholm in modern premises and is close to public transport facilities. The...

October 16, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Paris:DBV) (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today a partnership with Dr. Bernard Malissen who...

October 16, 2012

CHELMSFORD, Mass. & KAUFERING, Germany--(BUSINESS WIRE)--ZOLL Medical Corporation and GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, announced today that they have concluded a licensing...

October 15, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: On September 6th, 2012, Meda announced an acquisition of pharmaceutical products within Women’s Health from Jazz Pharmaceuticals. This acquisition has now been completed. The purchase price was...

October 15, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE: ENZ) today reported results for the fourth quarter and year ended July 31, 2012, and announced a Company-wide realignment program to improve profitability and reduce operating expenses. This...

October 15, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. FDA Approves Labeling Update for BARACLUDE® (entecavir) (0.5 mg/1 mg Tablets) to Include Data on African Americans and Liver Transplant Recipients with Chronic Hepatitis

October 15, 2012

CAMPBELL, Calif.--(BUSINESS WIRE)--Vital Connect, Inc. (VCI), a growing biosensor technology company, today announced that prominent cardiologist Neal White, MD, FACC, has joined its Medical Advisory Board.

October 15, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Paris:DBV) (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today its first nine months topline and its clinical...

October 15, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2012 third quarter financial results before the opening of the market on October 25, 2012. The Company will host a conference call at 8:00 a.m.,...

October 15, 2012

CHICAGO--(BUSINESS WIRE)--NEC Display's 21.3-inch medical diagnostic display receives FDA 510(K) market clearance.

October 15, 2012

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Results from STENTYS' APPOSITION III study of its Self-Apposing Stent are being presented at TCT. STENTYS is also hosting a satellite symposium to highlight its proposed U.S. clinical trial program....

October 15, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today new findings from the double-blind,...

October 15, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): The following people have been appointed as members of Vitrolife’s election committee for the Annual General Meeting in 2013: Henrik Blomquist, representing Bure Equity AB...

October 15, 2012

ANN ARBOR, Mich. & SAN DIEGO--(BUSINESS WIRE)--NanoBio announces that results from its nanoemulsion adjuvanted RSV vaccine will be presented at IDWeek 2012™ taking place from Oct. 17-21 in San Diego.

October 15, 2012

SADDLE BROOK, N.J.--(BUSINESS WIRE)--CircuLite and the SYNERGY Circulatory Support System, designed to halt the progression of heart failure, will be discussed in 4 presentations at Transcatheter Cardiovascular Therapeutics.

October 15, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, today announced that John L. Baird has been named to the newly created position of Senior Vice President of Sales and Business Development. John studied peptides...

October 15, 2012

EVRY, France--(BUSINESS WIRE)--PhinC Development strengthens its offer in pharmacometrics. This new PBPK service will be no longer reserved to “big pharma” but, now, to smaller biotechnology companies developing drugs.

October 15, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida CEO to describe sustained delivery nanotech technology for peptides, proteins and biosimilars at Mass Bio meeting

October 15, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. announced today that it has registered its South San Francisco facility as a medical device establishment with the U.S. Food and Drug Administration. The company plans to use...

October 15, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed European oncologists are most concerned about the risk of myocardial...

October 15, 2012

GENEVA--(BUSINESS WIRE)--Antibody drug orphan disease interferon monoclonal

October 15, 2012

TORONTO--(BUSINESS WIRE)--LES (USA & Canada) released preliminary results from its 2012 Global BioPharma Royalty Rates and Deal Terms Survey at their Annual meeting today. The final report will be released in November.

October 15, 2012

LEXINGTON, Mass. & CORALVILLE, Iowa--(BUSINESS WIRE)--RainDance Technologies and Integrated DNA Technologies Develop Reagents and Consumables for Digital PCR

October 15, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions today announced that it will host a financial analyst day on Monday, November 12, 2012 in New York City.

October 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera announces completion of enrollment in Phase 2 trial and upcoming milestones in autoimmune development programs including Phase 1 trial of novel lupus drug candidate to begin in 2012

October 15, 2012

ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf releases the next generation CelliGen BLU Single-Use Vessel with interchangeable pitched-blade 5, 14 and 50 L capacities and proprietary packed-bed impeller vessel for cell culture process.

October 15, 2012

LOS ANGELES--(BUSINESS WIRE)--The Gores Group announced that it has made a binding offer to acquire Therakos, Inc. from Ortho-Clinical Diagnostics, Inc.

October 15, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Investor Relations veteran Allison Wey joined Durata Therapeutics as VP, Investor Relations and Public Affairs, effective October 15, 2012.

October 15, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum named one of the Best Places to Work in Southern Nevada by the Southern Nevada Human Resources Association (SNHRA).

October 15, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Promedior announced that it has completed a $24.5 million Series D financing round, adding $3 million in a second closing of this financing round from new investor, Shire Strategic Investment Group.

October 15, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Promedior today announced the appointment of Elizabeth G. Trehu, M.D., as Chief Medical Officer (CMO).

October 15, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Bruker announced the launch today of the ContourGT-I 3D Optical Microscope to enhance R&D productivity and maximize manufacturing throughput for industrial applications. The ContourGT-I has been optimized to...

October 15, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2012 following the close of market on Tuesday, October 23, 2012. On the same day, at 2:00pm Pacific Time (5:00pm Eastern Time)...

October 15, 2012

VIENNA--(BUSINESS WIRE)--It was quite a crowd of medical experts that gathered for the presentations on “Windows of opportunity in age-related cognitive disorders” that took place in Vienna on the occasion of the ECNP on Saturday 13th. The...

October 14, 2012

LOUISVILLE, Ky.& BEIJING--(BUSINESS WIRE)--Pharmaron, a premier R&D service provider for the pharmaceutical and biotech industries, today announced a drug discovery partnership with AstraZeneca to support their global Innovative Medicines...

October 12, 2012

SEATTLE--(BUSINESS WIRE)--Chris Rivera, President of the Washington Biotechnology & Biomedical Association (WBBA) announced today that Jay Inslee and Rob McKenna have been confirmed as speakers at the Governor’s Life Sciences Summit and...

October 12, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2012 fourth quarter results on Tuesday, October 16, 2012, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International...

October 12, 2012

LYON, France--(BUSINESS WIRE)--Fab’entech, a French biopharmaceutical company specialized in developing specific polyclonal immunoglobulins against emerging infectious diseases announces that the company is launching its first clinical trial in...

October 12, 2012

SOUTH SAN FRANCISCO, Calif. & MÖLNDAL, Sweden--(BUSINESS WIRE)--Cellectricon AB and Fluxion Biosciences today announced that they have settled the patent infringement litigation that Cellectricon commenced against Fluxion in 2009....

October 12, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA® (...

October 12, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Launches SQiDliteTM Multiplexing System at AAPS

SQiDlite improves efficiency of drug development, clinical trials and immunogenicity testing

October 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today released a letter to Shareholders. To Our Shareholders...